Applied Biosystems Expands Its Line of siRNAs for Biomedical Research

FOSTER CITY, Calif.--(BUSINESS WIRE)--Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced the availability of a new line of synthetic short interfering ribonucleic acids (siRNA). Silencer® Select siRNAs expand the company’s portfolio of siRNA products and when compared to other leading commercial siRNAs, deliver the most consistent gene silencing and highest quality gene function data available to biomedical researchers performing ribonucleic acid interference (RNAi) experiments1.